29 August 2025 | 9:33AM CST Eyebright (688050.SS): Earnings Review: 1H25 results in line, see premiumization trend and share gain in IOLs; Buy Eyebright reported 1H25 results on Aug 27, 2025. 1H25 revenue grew by 14.7% (-1.3% vs. GSe), and net profits were in-line at Rmb213mn (+2.5% yoy, -4.4% vs. GSe). IOL sales grew by 8.2% yoy in 1H25 (including PIOL product per company breakdown) despite industry cataract surgery volume decrease, implying that Eyebright continues to gain share and sees continuing premiu ...